Goldman Sachs Group Inc Bio Rad Laboratories, Inc. Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 72,132 shares of BIO stock, worth $18.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,132

Previous 77,767 7.25%

Holding current value

$18.8 Million

Previous $26 Million 8.93%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$313.15 - $374.28 $1.76 Million - $2.11 Million	-5,635 Reduced 7.25%	72,132 $23.7 Million
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $15.1 Million - $19.7 Million	-57,160 Reduced 42.36%	77,767 $26 Million
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $21.2 Million - $26.9 Million	79,157 Added 141.93%	134,927 $36.8 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $26.9 Million - $31.2 Million	-88,563 Reduced 61.36%	55,770 $19.3 Million
Q4 2023 Feb 13, 2024	BUY	$269.37 - $365.04 $31.9 Million - $43.2 Million	118,304 Added 454.51%	144,333 $46.6 Million
Q3 2023 May 14, 2024	SELL	$350.25 - $422.63 $41.4 Million - $50 Million	-118,304 Reduced 81.97%	26,029 $9.33 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $5.52 Million - $6.66 Million	-15,770 Reduced 37.73%	26,029 $9.33 Million
Q2 2023 May 14, 2024	BUY	$359.49 - $486.4 $2.75 Million - $3.72 Million	7,650 Added 22.4%	41,799 $15.8 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $2.75 Million - $3.72 Million	7,650 Added 22.4%	41,799 $15.8 Million
Q1 2023 May 14, 2024	BUY	$418.69 - $503.0 $4.17 Million - $5.01 Million	9,960 Added 41.18%	34,149 $16.4 Million
Q1 2023 May 11, 2023	BUY	$418.69 - $503.0 $4.17 Million - $5.01 Million	9,960 Added 41.18%	34,149 $16.4 Million
Q4 2022 May 14, 2024	SELL	$351.71 - $456.01 $7.58 Million - $9.83 Million	-21,560 Reduced 47.13%	24,189 $10.2 Million
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $7.58 Million - $9.83 Million	-21,560 Reduced 47.13%	24,189 $10.2 Million
Q3 2022 May 14, 2024	BUY	$412.59 - $563.26 $5.87 Million - $8.02 Million	14,234 Added 45.17%	45,749 $19.1 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $5.87 Million - $8.02 Million	14,234 Added 45.17%	45,749 $19.1 Million
Q2 2022 May 14, 2024	SELL	$463.67 - $597.16 $52.3 Million - $67.4 Million	-112,818 Reduced 78.17%	31,515 $15.6 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $23.2 Million - $29.9 Million	-50,030 Reduced 61.35%	31,515 $15.6 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $600,108 - $841,320	1,144 Added 1.42%	81,545 $45.9 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $1.14 Million - $1.28 Million	1,615 Added 2.05%	80,401 $60.7 Million
Q3 2021 Nov 10, 2021	BUY	$657.71 - $825.77 $51.8 Million - $65.1 Million	78,786 New	78,786 $58.8 Million

Others Institutions Holding BIO

# of Institutions

478

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Bio Rad Laboratories, Inc. Transaction History